{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:50:29Z","timestamp":1790297429624,"version":"4.1.0"},"reference-count":137,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.beem.2020.101428","type":"journal-article","created":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T02:37:02Z","timestamp":1590201422000},"page":"101428","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Adrenocortical tumorigenesis: Lessons from genetics"],"prefix":"10.1016","volume":"34","author":[{"given":"Crystal D.C.","family":"Kamilaris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fady","family":"Hannah-Shmouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine A.","family":"Stratakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.beem.2020.101428_bib1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2265.1994.tb02486.x","article-title":"Morbidity and mortality in Cushing's disease: an epidemiological approach","volume":"40","author":"Etxabe","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.beem.2020.101428_bib2","first-page":"117","article-title":"Incidence and late prognosis of cushing's syndrome: a population-based study","volume":"86","author":"Lindholm","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9996","key":"10.1016\/j.beem.2020.101428_bib3","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing's syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.beem.2020.101428_bib4","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/ncpendmet0648","article-title":"Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias","volume":"3","author":"Stratakis","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metabol"},{"issue":"3","key":"10.1016\/j.beem.2020.101428_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/a-1107-2972","article-title":"A\u00a0gene-based classification of primary adrenocortical hyperplasias","volume":"52","author":"Hannah-Shmouni","year":"2020","journal-title":"Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme"},{"issue":"10","key":"10.1016\/j.beem.2020.101428_bib6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nrm3432","article-title":"Assembly of allosteric macromolecular switches: lessons from PKA","volume":"13","author":"Taylor","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"24","key":"10.1016\/j.beem.2020.101428_bib7","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM199112123252403","article-title":"Activating mutations of the stimulatory G protein in the McCune-Albright syndrome","volume":"325","author":"Weinstein","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2020.101428_bib8","series-title":"GeneReviews((R))","article-title":"Fibrous dysplasia\/McCune-albright syndrome","author":"Boyce","year":"1993"},{"issue":"9","key":"10.1016\/j.beem.2020.101428_bib9","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/PAS.0b013e31821ec4ce","article-title":"Primary bimorphic adrenocortical disease: cause of hypercortisolism in McCune-Albright syndrome","volume":"35","author":"Carney","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"7\u20138 Pt 2","key":"10.1016\/j.beem.2020.101428_bib10","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.lpm.2018.07.005","article-title":"Genetics of micronodular adrenal hyperplasia and Carney complex","volume":"47","author":"Tirosh","year":"2018","journal-title":"Presse Med"},{"issue":"6","key":"10.1016\/j.beem.2020.101428_bib11","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1210\/jc.2008-2333","article-title":"Mutations in regulatory subunit type 1A of cyclic adenosine 5'-monophosphate-dependent protein kinase (PRKAR1A): phenotype analysis in 353 patients and 80 different genotypes","volume":"94","author":"Bertherat","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2020.101428_bib12","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00005792-198507000-00007","article-title":"The complex of myxomas, spotty pigmentation, and endocrine overactivity","volume":"64","author":"Carney","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.beem.2020.101428_bib13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000345669","article-title":"Carney complex","volume":"41","author":"Espiard","year":"2013","journal-title":"Front Horm Res"},{"issue":"2\u201303","key":"10.1016\/j.beem.2020.101428_bib14","first-page":"156","article-title":"Carney complex","volume":"127","author":"Kamilaris","year":"2019","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"9","key":"10.1016\/j.beem.2020.101428_bib15","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1210\/jcem.86.9.7903","article-title":"Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation","volume":"86","author":"Stratakis","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2020.101428_bib16","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11102-006-0266-1","article-title":"PRKAR1A mutations in primary pigmented nodular adrenocortical disease","volume":"9","author":"Cazabat","year":"2006","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.beem.2020.101428_bib17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/79238","article-title":"Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex","volume":"26","author":"Kirschner","year":"2000","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.beem.2020.101428_bib18","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1530\/ERC-17-0361","article-title":"Genetics of tumors of the adrenal cortex","volume":"25","author":"Bonnet-Serrano","year":"2018","journal-title":"Endocr Relat Canc"},{"issue":"4","key":"10.1016\/j.beem.2020.101428_bib19","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/ajmg.a.30279","article-title":"Eyelid myxoma in Carney complex without PRKAR1A allelic loss","volume":"130A","author":"Tsilou","year":"2004","journal-title":"Am J Med Genet"},{"issue":"13","key":"10.1016\/j.beem.2020.101428_bib20","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/hmg\/ddg160","article-title":"Protein kinase-A activity in PRKAR1A-mutant cells, and regulation of mitogen-activated protein kinases ERK1\/2","volume":"12","author":"Robinson-White","year":"2003","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.beem.2020.101428_bib21","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/jmg.40.4.268","article-title":"Chromosome 2 (2p16) abnormalities in Carney complex tumours","volume":"40","author":"Matyakhina","year":"2003","journal-title":"J\u00a0Med Genet"},{"issue":"3","key":"10.1016\/j.beem.2020.101428_bib22","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1172\/JCI118467","article-title":"Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2","volume":"97","author":"Stratakis","year":"1996","journal-title":"J\u00a0Clin Invest"},{"issue":"11","key":"10.1016\/j.beem.2020.101428_bib23","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJMc1309730","article-title":"PRKACB and Carney complex","volume":"370","author":"Forlino","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"17","key":"10.1016\/j.beem.2020.101428_bib24","first-page":"5308","article-title":"Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity","volume":"63","author":"Bertherat","year":"2003","journal-title":"Canc Res"},{"issue":"2","key":"10.1016\/j.beem.2020.101428_bib25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1210\/jc.2011-3327","article-title":"Adrenocortical cancer in Carney complex: a paradigm of endocrine tumor progression or an association of genetic predisposing factors?","volume":"97","author":"Bertherat","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.beem.2020.101428_bib26","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1210\/js.2017-00231","article-title":"Corticotropinoma as a component of Carney complex","volume":"1","author":"Hernandez-Ramirez","year":"2017","journal-title":"J\u00a0Endocr Soc"},{"issue":"7","key":"10.1016\/j.beem.2020.101428_bib27","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/ng1809","article-title":"A\u00a0genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia","volume":"38","author":"Horvath","year":"2006","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.beem.2020.101428_bib28","doi-asserted-by":"crossref","first-page":"E208","DOI":"10.1210\/jc.2010-1704","article-title":"Frequent phosphodiesterase 11A gene (PDE11A) defects in patients with Carney complex (CNC) caused by PRKAR1A mutations: PDE11A may contribute to adrenal and testicular tumors in CNC as a modifier of the phenotype","volume":"96","author":"Libe","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.beem.2020.101428_bib29","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.1158\/1078-0432.CCR-08-0106","article-title":"Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors","volume":"14","author":"Libe","year":"2008","journal-title":"Clin Canc Res"},{"issue":"1","key":"10.1016\/j.beem.2020.101428_bib30","doi-asserted-by":"crossref","first-page":"E135","DOI":"10.1210\/jc.2010-1655","article-title":"Phosphodiesterase 11A (PDE11A) genetic variants may increase susceptibility to prostatic cancer","volume":"96","author":"Faucz","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2020.101428_bib31","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1530\/ERC-15-0034","article-title":"Rare inactivating PDE11A variants associated with testicular germ cell tumors","volume":"22","author":"Pathak","year":"2015","journal-title":"Endocr Relat Canc"},{"issue":"7","key":"10.1016\/j.beem.2020.101428_bib32","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1056\/NEJMc0706182","article-title":"Mutation in PDE8B, a cyclic AMP-specific phosphodiesterase in adrenal hyperplasia","volume":"358","author":"Horvath","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.beem.2020.101428_bib33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1365-2265.2012.04366.x","article-title":"Identification of novel genetic variants in phosphodiesterase 8B (PDE8B), a cAMP-specific phosphodiesterase highly expressed in the adrenal cortex, in a cohort of patients with adrenal tumours","volume":"77","author":"Rothenbuhler","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"10.1016\/j.beem.2020.101428_bib34","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1310359","article-title":"Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome","volume":"370","author":"Beuschlein","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.beem.2020.101428_bib35","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1530\/EJE-14-1154","article-title":"Germline PRKACA amplification causes variable phenotypes that may depend on the extent of the genomic defect: molecular mechanisms and clinical presentations","volume":"172","author":"Lodish","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2020.101428_bib36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","article-title":"Wnt\/beta-Catenin signaling: components, mechanisms, and diseases","volume":"17","author":"MacDonald","year":"2009","journal-title":"Dev Cell"},{"issue":"3","key":"10.1016\/j.beem.2020.101428_bib37","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2265.2008.03273.x","article-title":"Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD)","volume":"69","author":"Tadjine","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"10.1016\/j.beem.2020.101428_bib38","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1210\/jc.2008-0631","article-title":"Wnt\/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate\/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors","volume":"93","author":"Gaujoux","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"22","key":"10.1016\/j.beem.2020.101428_bib39","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1056\/NEJMoa1215245","article-title":"Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia","volume":"369","author":"Louiset","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.beem.2020.101428_bib40","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1210\/jc.2009-0516","article-title":"Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors","volume":"94","author":"Hsiao","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2020.101428_bib41","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1365-2265.2008.03471.x","article-title":"Familial vasopressin-sensitive ACTH-independent macronodular adrenal hyperplasia (VPs-AIMAH): clinical studies of three kindreds","volume":"70","author":"Gagliardi","year":"2009","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2020.101428_bib42","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-8-142","article-title":"ACTH-independent macronodular adrenocortical hyperplasia reveals prevalent aberrant in\u00a0vivo and in\u00a0vitro responses to hormonal stimuli and coupling of arginine-vasopressin type 1a receptor to 11 beta-hydroxylase","volume":"8","author":"Hofland","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"10.1016\/j.beem.2020.101428_bib43","first-page":"747","article-title":"Catecholamine-dependent hereditary Cushing's syndrome - follow-up after unilateral adrenalectomy","volume":"97","author":"Imohl","year":"2002","journal-title":"Med Klin"},{"issue":"14","key":"10.1016\/j.beem.2020.101428_bib44","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJM199210013271402","article-title":"Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome","volume":"327","author":"Lacroix","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.beem.2020.101428_bib45","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJM199911183412104","article-title":"Leuprolide acetate therapy in luteinizing hormone--dependent Cushing's syndrome","volume":"341","author":"Lacroix","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.beem.2020.101428_bib46","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1365-2265.2005.02387.x","article-title":"Ectopic expression of vasopressin V1b and V2 receptors in the adrenal glands of familial ACTH-independent macronodular adrenal hyperplasia","volume":"63","author":"Lee","year":"2005","journal-title":"Clin Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2020.101428_bib47","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1530\/EJE-10-0195","article-title":"Aberrant cortisol regulations in bilateral macronodular adrenal hyperplasia: a frequent finding in a prospective study of 32 patients with overt or subclinical Cushing's syndrome","volume":"163","author":"Libe","year":"2010","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"10.1016\/j.beem.2020.101428_bib48","first-page":"3531","article-title":"Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing's syndrome?","volume":"85","author":"Mircescu","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.beem.2020.101428_bib49","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1385\/ENDO:19:3:319","article-title":"Inherited adrenocorticotropin-independent macronodular adrenal hyperplasia with abnormal cortisol secretion by vasopressin and catecholamines - detection of the aberrant hormone receptors on adrenal gland","volume":"19","author":"Miyamura","year":"2002","journal-title":"Endocrine"},{"issue":"14","key":"10.1016\/j.beem.2020.101428_bib50","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJM199210013271403","article-title":"Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide","volume":"327","author":"Reznik","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.beem.2020.101428_bib51","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1530\/eje.1.02324","article-title":"Familial adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors","volume":"156","author":"Vezzosi","year":"2007","journal-title":"Eur J Endocrinol"},{"issue":"18","key":"10.1016\/j.beem.2020.101428_bib52","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92184","article-title":"Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing's syndrome","volume":"2","author":"Lecoq","year":"2017","journal-title":"JCI Insight"},{"issue":"11","key":"10.1016\/j.beem.2020.101428_bib53","doi-asserted-by":"crossref","first-page":"E2063","DOI":"10.1210\/jc.2012-2275","article-title":"Phosphodiesterase 11A (PDE11A) gene defects in patients with acth-independent macronodular adrenal hyperplasia (AIMAH): functional variants may contribute to genetic susceptibility of bilateral adrenal tumors","volume":"97","author":"Vezzosi","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2020.101428_bib54","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1210\/jc.2009-2321","article-title":"Cushing syndrome in the McCune-Albright syndrome","volume":"95","author":"Brown","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.beem.2020.101428_bib55","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1210\/jc.2005-2608","article-title":"17q22-24 chromosomal losses and alterations of protein kinase a subunit expression and activity in adrenocorticotropin-independent macronodular adrenal hyperplasia","volume":"91","author":"Bourdeau","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2020.101428_bib56","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.mce.2003.10.052","article-title":"Constitutive activation of the human ACTH receptor resulting from a synergistic interaction between two naturally occurring missense mutations in the MC2R gene","volume":"213","author":"Swords","year":"2004","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2020.101428_bib57","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/EJE-11-0679","article-title":"Adrenal involvement in MEN1. Analysis of 715 cases from the Groupe d'etude des Tumeurs Endocrines database","volume":"166","author":"Gatta-Cherifi","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"21","key":"10.1016\/j.beem.2020.101428_bib58","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1158\/1078-0432.CCR-10-1497","article-title":"Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers","volume":"16","author":"Gaujoux","year":"2010","journal-title":"Clin Canc Res"},{"issue":"2","key":"10.1016\/j.beem.2020.101428_bib59","first-page":"430","article-title":"Adrenal nodular hyperplasia in hereditary leiomyomatosis and renal cell cancer","volume":"189","author":"Shuch","year":"2013","journal-title":"J\u00a0Urol"},{"issue":"22","key":"10.1016\/j.beem.2020.101428_bib60","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa1304603","article-title":"ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome","volume":"369","author":"Assie","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.beem.2020.101428_bib61","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1097\/DCR.0000000000001008","article-title":"Characteristics of adrenal masses in familial adenomatous polyposis","volume":"61","author":"Shiroky","year":"2018","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.beem.2020.101428_bib62","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fendo.2019.00339","article-title":"Multiple endocrine neoplasia type 1 (MEN1): an update and the significance of early genetic and clinical diagnosis","volume":"10","author":"Kamilaris","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5311","key":"10.1016\/j.beem.2020.101428_bib63","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.beem.2020.101428_bib64","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/hmg\/6.7.1177","article-title":"Identification of the multiple endocrine neoplasia type 1 (MEN1) gene","volume":"6","author":"Lemmens","year":"1997","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.beem.2020.101428_bib65","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/humu.20605","article-title":"Multiple endocrine neoplaslia type 1 (MEN 1): analysis of 1336 mutations reported in the first decade following identification of the gene","volume":"29","author":"Lemos","year":"2008","journal-title":"Hum Mutat"},{"issue":"8","key":"10.1016\/j.beem.2020.101428_bib66","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.tibs.2013.05.005","article-title":"Menin: a scaffold protein that controls gene expression and cell signaling","volume":"38","author":"Matkar","year":"2013","journal-title":"Trends Biochem Sci"},{"issue":"5","key":"10.1016\/j.beem.2020.101428_bib67","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1086\/320124","article-title":"Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3-q43","volume":"68","author":"Alam","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.beem.2020.101428_bib68","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/path.1686","article-title":"Evidence of increased microvessel density and activation of the hypoxia pathway in tumours from the hereditary leiomyomatosis and renal cell cancer syndrome","volume":"205","author":"Pollard","year":"2005","journal-title":"J\u00a0Pathol"},{"issue":"2","key":"10.1016\/j.beem.2020.101428_bib69","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ncpuro0711","article-title":"Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer","volume":"4","author":"Sudarshan","year":"2007","journal-title":"Nat Clin Pract Urol"},{"issue":"6","key":"10.1016\/j.beem.2020.101428_bib70","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1210\/jc.2004-2377","article-title":"Hereditary leiomyomatosis associated with bilateral, massive, macronodular adrenocortical disease and atypical cushing syndrome: a clinical and molecular genetic investigation","volume":"90","author":"Matyakhina","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2020.101428_bib71","doi-asserted-by":"crossref","first-page":"E926","DOI":"10.1210\/jc.2014-4204","article-title":"ARMC5 mutations in a large cohort of primary macronodular adrenal hyperplasia: clinical and functional consequences","volume":"100","author":"Espiard","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2020.101428_bib72","doi-asserted-by":"crossref","first-page":"E1113","DOI":"10.1210\/jc.2013-4280","article-title":"Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation","volume":"99","author":"Faucz","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2020.101428_bib73","doi-asserted-by":"crossref","first-page":"13834","DOI":"10.1038\/ncomms13834","article-title":"Armc5 deletion causes developmental defects and compromises T-cell immune responses","volume":"8","author":"Hu","year":"2017","journal-title":"Nat Commun"},{"issue":"17","key":"10.1016\/j.beem.2020.101428_bib74","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1158\/0008-5472.CAN-05-0593","article-title":"Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors","volume":"65","author":"Tissier","year":"2005","journal-title":"Canc Res"},{"issue":"18","key":"10.1016\/j.beem.2020.101428_bib75","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1093\/hmg\/ddx235","article-title":"Age-dependent effects of Armc5 haploinsufficiency on adrenocortical function","volume":"26","author":"Berthon","year":"2017","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.beem.2020.101428_bib76","doi-asserted-by":"crossref","first-page":"E900","DOI":"10.1210\/jc.2014-4167","article-title":"Primary aldosteronism and ARMC5 variants","volume":"100","author":"Zilbermint","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2020.101428_bib77","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.1210\/jc.2014-2648","article-title":"Molecular and clinical evidence for an ARMC5 tumor syndrome: concurrent inactivating germline and somatic mutations are associated with both primary macronodular adrenal hyperplasia and meningioma","volume":"100","author":"Elbelt","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2020.101428_bib78","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10689-013-9642-y","article-title":"Whole exome sequencing identifies mutation of EDNRA involved in ACTH-independent macronodular adrenal hyperplasia","volume":"12","author":"Zhu","year":"2013","journal-title":"Fam Cancer"},{"issue":"3","key":"10.1016\/j.beem.2020.101428_bib79","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/path.5014","article-title":"Cyclic AMP-dependent protein kinase catalytic subunit A (PRKACA): the expected, the unexpected, and what might be next","volume":"244","author":"Stratakis","year":"2018","journal-title":"J\u00a0Pathol"},{"issue":"5","key":"10.1016\/j.beem.2020.101428_bib80","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrendo.2016.24","article-title":"A\u00a0genetic and molecular update on adrenocortical causes of Cushing syndrome","volume":"12","author":"Lodish","year":"2016","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2020.101428_bib81","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/en.2018-00775","article-title":"Alterations in protein kinase A substrate specificity as a potential cause of cushing syndrome","volume":"160","author":"Bathon","year":"2019","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.beem.2020.101428_bib82","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98296","article-title":"Activating PRKACB somatic mutation in cortisol-producing adenomas","volume":"3","author":"Espiard","year":"2018","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.beem.2020.101428_bib83","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1530\/EJE-09-0027","article-title":"Abnormalities of cAMP signaling are present in adrenocortical lesions associated with ACTH-independent Cushing syndrome despite the absence of mutations in known genes","volume":"161","author":"Bimpaki","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.beem.2020.101428_bib84","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2020.101428_bib85","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1152\/physrev.00030.2003","article-title":"Control of aldosterone secretion: a model for convergence in cellular signaling pathways","volume":"84","author":"Spat","year":"2004","journal-title":"Physiol Rev"},{"issue":"11","key":"10.1016\/j.beem.2020.101428_bib86","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A\u00a0prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.beem.2020.101428_bib87","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2265.2007.02775.x","article-title":"Primary aldosteronism: renaissance of a syndrome","volume":"66","author":"Young","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6357","key":"10.1016\/j.beem.2020.101428_bib88","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A\u00a0chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension","volume":"355","author":"Lifton","year":"1992","journal-title":"Nature"},{"issue":"22","key":"10.1016\/j.beem.2020.101428_bib89","first-page":"1109","article-title":"Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone","volume":"95","author":"Sutherland","year":"1966","journal-title":"Can Med Assoc J"},{"issue":"3","key":"10.1016\/j.beem.2020.101428_bib90","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41588-018-0048-5","article-title":"CLCN2 chloride channel mutations in familial hyperaldosteronism type II","volume":"50","author":"Scholl","year":"2018","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.beem.2020.101428_bib91","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41588-018-0053-8","article-title":"A\u00a0gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism","volume":"50","author":"Fernandes-Rosa","year":"2018","journal-title":"Nat Genet"},{"issue":"6018","key":"10.1016\/j.beem.2020.101428_bib92","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.beem.2020.101428_bib93","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/ajh\/hpz172","article-title":"Mosaicism for KCNJ5 causing early-onset primary aldosteronism due to bilateral adrenocortical hyperplasia","volume":"33","author":"Maria","year":"2020","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.beem.2020.101428_bib94","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.06315","article-title":"Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism","volume":"4","author":"Scholl","year":"2015","journal-title":"Elife"},{"issue":"9","key":"10.1016\/j.beem.2020.101428_bib95","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/ng.2695","article-title":"Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism","volume":"45","author":"Scholl","year":"2013","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.beem.2020.101428_bib96","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ng.2716","article-title":"Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension","volume":"45","author":"Azizan","year":"2013","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.beem.2020.101428_bib97","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ng.2550","article-title":"Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension","volume":"45","author":"Beuschlein","year":"2013","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.beem.2020.101428_bib98","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/HYPERTENSIONAHA.114.03419","article-title":"Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma","volume":"64","author":"Fernandes-Rosa","year":"2014","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"issue":"7","key":"10.1016\/j.beem.2020.101428_bib99","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041926","article-title":"Comprehensive Re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter","volume":"7","author":"Akerstrom","year":"2012","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.beem.2020.101428_bib100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147590","article-title":"Genetics of aldosterone-producing adenoma in Korean patients","volume":"11","author":"Hong","year":"2016","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.beem.2020.101428_bib101","doi-asserted-by":"crossref","first-page":"E1089","DOI":"10.1210\/jc.2015-2149","article-title":"A\u00a0meta-analysis of somatic KCNJ5 K+ channel mutations in 1636 patients with an aldosterone-producing adenoma","volume":"100","author":"Lenzini","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2020.101428_bib102","article-title":"Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population","volume":"5","author":"Wu","year":"2015","journal-title":"Sci Rep-Uk"},{"issue":"3","key":"10.1016\/j.beem.2020.101428_bib103","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/HYPERTENSIONAHA.111.186478","article-title":"Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism","volume":"59","author":"Boulkroun","year":"2012","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"issue":"11","key":"10.1016\/j.beem.2020.101428_bib104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0337-9","article-title":"Genetic causes of primary aldosteronism","volume":"51","author":"Seidel","year":"2019","journal-title":"Exp Mol Med"},{"issue":"4","key":"10.1016\/j.beem.2020.101428_bib105","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/HYPERTENSIONAHA.118.12070","article-title":"Genetic characteristics of aldosterone-producing adenomas in blacks","volume":"73","author":"Nanba","year":"2019","journal-title":"Hypertension (Dallas, Tex : 1979)"},{"key":"10.1016\/j.beem.2020.101428_bib106","doi-asserted-by":"crossref","first-page":"19546","DOI":"10.1038\/srep19546","article-title":"Activating mutations in CTNNB1 in aldosterone producing adenomas","volume":"6","author":"Akerstrom","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.beem.2020.101428_bib107","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/hmg\/ddt484","article-title":"WNT\/beta-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production","volume":"23","author":"Berthon","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.beem.2020.101428_bib108","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/cen.12873","article-title":"Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype","volume":"83","author":"Scholl","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.beem.2020.101428_bib109","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1365-2265.2007.03033.x","article-title":"Frequent mutations of beta-catenin gene in sporadic secreting adrenocortical adenomas","volume":"68","author":"Tadjine","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"15","key":"10.1016\/j.beem.2020.101428_bib110","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJMoa1504869","article-title":"Pregnancy, primary aldosteronism, and adrenal CTNNB1 mutations","volume":"373","author":"Teo","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.beem.2020.101428_bib111","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1210\/jc.2005-2639","article-title":"Clinical review: adrenocortical carcinoma: clinical update","volume":"91","author":"Allolio","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2020.101428_bib112","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/(SICI)1097-0215(19960208)65:4<432::AID-IJC6>3.0.CO;2-Y","article-title":"Risk factors for adrenal cancer: an exploratory study","volume":"65","author":"Hsing","year":"1996","journal-title":"Int J Canc"},{"issue":"1","key":"10.1016\/j.beem.2020.101428_bib113","first-page":"5","article-title":"Adrenocortical carcinoma: diagnosis, evaluation and treatment","volume":"169","author":"Ng","year":"2003","journal-title":"J\u00a0Urol"},{"issue":"2","key":"10.1016\/j.beem.2020.101428_bib114","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1210\/jc.2011-2244","article-title":"A\u00a0large family with Carney complex caused by the S147G PRKAR1A mutation shows a unique spectrum of disease including adrenocortical cancer","volume":"97","author":"Anselmo","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2020.101428_bib115","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr Rev"},{"issue":"7\u20138 Pt 2","key":"10.1016\/j.beem.2020.101428_bib116","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1016\/j.lpm.2018.07.004","article-title":"Adrenocortical carcinoma (ACC): when and why should we consider germline testing?","volume":"47","author":"Petr","year":"2018","journal-title":"Presse Med"},{"issue":"4985","key":"10.1016\/j.beem.2020.101428_bib117","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.1978757","article-title":"Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms","volume":"250","author":"Malkin","year":"1990","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.beem.2020.101428_bib118","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mce.2011.09.010","article-title":"Towards an understanding of the role of p53 in adrenocortical carcinogenesis","volume":"351","author":"Wasserman","year":"2012","journal-title":"Mol Cell Endocrinol"},{"issue":"23","key":"10.1016\/j.beem.2020.101428_bib119","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1002\/cncr.30248","article-title":"Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort","volume":"122","author":"Mai","year":"2016","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.beem.2020.101428_bib120","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.1210\/jc.2012-2198","article-title":"Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma","volume":"98","author":"Raymond","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2020.101428_bib121","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1200\/JCO.2013.52.6863","article-title":"Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study","volume":"33","author":"Wasserman","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"20","key":"10.1016\/j.beem.2020.101428_bib122","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1200\/JCO.2012.46.3711","article-title":"Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors","volume":"31","author":"Custodio","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"15","key":"10.1016\/j.beem.2020.101428_bib123","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jama.2012.13088","article-title":"Identification of Lynch syndrome among patients with colorectal cancer","volume":"308","author":"Moreira","year":"2012","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.beem.2020.101428_bib124","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1200\/JCO.2012.48.0988","article-title":"Adrenocortical carcinoma is a lynch syndrome-associated cancer","volume":"31","author":"Raymond","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"1","key":"10.1016\/j.beem.2020.101428_bib125","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ajmg.c.30064","article-title":"Risk of tumorigenesis in overgrowth syndromes: a comprehensive review","volume":"137C","author":"Lapunzina","year":"2005","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/j.beem.2020.101428_bib126","series-title":"GeneReviews((R))","article-title":"Beckwith-wiedemann syndrome","author":"Shuman","year":"1993"},{"issue":"1","key":"10.1016\/j.beem.2020.101428_bib127","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ejhg.2009.106","article-title":"Beckwith-Wiedemann syndrome","volume":"18","author":"Weksberg","year":"2010","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"10.1016\/j.beem.2020.101428_bib128","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1017\/S0317167100033990","article-title":"Neurofibromatosis type 1: piecing the puzzle together","volume":"25","author":"Feldkamp","year":"1998","journal-title":"Can J Neurol Sci"},{"issue":"1","key":"10.1016\/j.beem.2020.101428_bib129","first-page":"20","article-title":"Precise localization of NF1 to 17q11.2 by balanced translocation","volume":"44","author":"Ledbetter","year":"1989","journal-title":"Am J Hum Genet"},{"issue":"4","key":"10.1016\/j.beem.2020.101428_bib130","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1517\/13543784.2013.772979","article-title":"Optimizing biologically targeted clinical trials for neurofibromatosis","volume":"22","author":"Gutmann","year":"2013","journal-title":"Expet Opin Invest Drugs"},{"issue":"4","key":"10.1016\/j.beem.2020.101428_bib131","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(90)90150-D","article-title":"The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21","volume":"63","author":"Martin","year":"1990","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.beem.2020.101428_bib132","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<14::AID-AJMG5>3.0.CO;2-4","article-title":"Hyperactive Ras as a therapeutic target in neurofibromatosis type 1","volume":"89","author":"Weiss","year":"1999","journal-title":"Am J Med Genet"},{"issue":"2","key":"10.1016\/j.beem.2020.101428_bib133","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12020506","article-title":"Germline variants in phosphodiesterase genes and genetic predisposition to pediatric adrenocortical tumors","volume":"12","author":"Pinto","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.beem.2020.101428_bib134","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/ng.2953","article-title":"Integrated genomic characterization of adrenocortical carcinoma","volume":"46","author":"Assie","year":"2014","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/j.beem.2020.101428_bib135","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccell.2016.04.002","article-title":"Comprehensive pan-genomic characterization of adrenocortical carcinoma","volume":"29","author":"Zheng","year":"2016","journal-title":"Canc Cell"},{"issue":"3","key":"10.1016\/j.beem.2020.101428_bib136","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1210\/jc.2002-021117","article-title":"A\u00a0case report in favor of a multistep adrenocortical tumorigenesis","volume":"88","author":"Bernard","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2020.101428_bib137","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1530\/EJE-19-0811","article-title":"Genetics in endocrinology: glucocorticoid resistance syndrome","volume":"182","author":"Vitellius","year":"2020","journal-title":"Eur J Endocrinol"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X20300555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X20300555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:56:15Z","timestamp":1761497775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X20300555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":137,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1521690X20300555"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2020.101428","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adrenocortical tumorigenesis: Lessons from genetics","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2020.101428","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101428"}}